Search - tctmd.com

Displaying 1 - 20 of 69

Sort: Relevancy | Date

Quality of Anticoagulation Therapy Lower in Black Patients With A-fib

News Daily News

Quality of Anticoagulation Therapy Lower in Black Patients With A-fib

December 03, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

November 11, 2018

PFO Closure Registry Confirms Risk of New-Onset A-fib

News Daily News

PFO Closure Registry Confirms Risk of New-Onset A-fib

Yael L. Maxwell

November 09, 2018

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

News Daily News

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

Yael L. Maxwell

November 01, 2018

Higher Dose of Heparin Prevents Radial Artery Occlusion After Transradial Angiography

News Daily News

Higher Dose of Heparin Prevents Radial Artery Occlusion After Transradial Angiography

October 31, 2018

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

News Daily News

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

October 26, 2018

New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk

News Daily News

New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk

Yael L. Maxwell

October 16, 2018

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

Patients With A-fib and Cancer May Benefit From Visiting With a Cardiologist Early On

News Daily News

Patients With A-fib and Cancer May Benefit From Visiting With a Cardiologist Early On

October 10, 2018

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

News Daily News

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

October 09, 2018

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

October 04, 2018

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

News Daily News

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

October 03, 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

September 24, 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

September 24, 2018

OAC-ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Coronary Stent Implantation

Presentation TCT 2018

OAC-ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Coronary Stent Implantation

Presenter: Gregg W. Stone, Yukiko Nakano

September 24, 2018

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

Presentation TCT 2018

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

Presenter: Davide Capodanno, Giulio Stefanini, Robert A. Byrne

September 23, 2018

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

Presentation TCT 2018

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo

September 23, 2018

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Presentation TCT 2018

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Presenter: Davide Capodanno, Giulio Stefanini, Freek W.A. Verheugt

September 23, 2018

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Presentation TCT 2018

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Presenter: Davide Capodanno, Giulio Stefanini, C. Michael Gibson

September 23, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.